Codexis makes engineered enzymes and manufacturing services that help pharmaceutical companies produce drug therapeutics. CDXS reports earnings on Thu, Nov 12, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 17 | Piper Sandler | Maintained | Buy |
Whale Options Flow
90DNo whale options trades in CDXS in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CDXS is in one of them and how their past CDXS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered CDXS in an article yet. Here's the latest on the wider market.
CDXS Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Lamar SmithR · TX | Buy | $1K – $15K | Apr 6, 2018 | May 8, 2018 | 32 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Codexis
Codexis develops engineered enzymes and other proteins that improve how drugs are made, using its CodeEvolver platform. Its ECO Synthesis platform uses enzymes to manufacture RNA interference therapeutics, and it offers method development, process development and manufacturing support to drug developers. Its small molecule business sells optimized enzymes to large pharmaceutical companies to raise yields and purity. The company is based in Redwood City, California.
- Headquarters
- Redwood City, CA
- Founded
- 2002
- Website
- codexis.com ↗